Showing posts with label Human Immunodeficiency Virus. Show all posts
Showing posts with label Human Immunodeficiency Virus. Show all posts

Tuesday, 18 October 2016

Global Viral Infections Market to grow CAGR at 6.8% in 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics

ResearchMoz added Latest Research Report titled " Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics " to it's Large Report database.

Viruses are infectious particles comprising a nucleic acid core – consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Viruses replicate by exploiting the resources of their host cells, usually to the detriment of the host. As viral pathogens are exceptionally diverse, the morbidity associated with viral infections varies significantly depending on the virus in question. This report covers all viral infections, although particular focus is given to four key indications within this disease cluster: Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and influenza. The global viral infections market was valued at $74.0 billion in 2014, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 6.8%, reaching $117.6 billion in 2021. Key drivers of this growth will be the expanding treatment population and uptake of recently approved highly priced antiviral agents, as well as promising late-stage candidates that are expected to be priced highly.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=716911

Scope

The viral infections market is large and growing rapidly

    How do epidemiology trends differ among the key indications?
    What therapeutic options exist for preventing and treating viral infections?
    Which products and companies dominate the market?

The pipeline is innovative and diverse

    What is the proportion of early- to late-stage pipeline products?
    Which molecular targets are most prominent within the pipeline?
    How do the key indications differ in terms of molecule type?

Considerable market growth is anticipated throughout 2021

    Which products will contribute to this growth most significantly?
    Will the current market leaders retain their dominance over the forecast period?

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 9
2.1 Therapy Area Introduction 9
2.2 Human Immunodeficiency Virus (HIV) 9
2.2.1 Overview 9
2.2.2 Symptoms 10
2.2.3 Co-morbidities and Complications 10
2.2.4 Epidemiology 11
2.3 Hepatitis C Virus 12
2.3.1 Overview 12
2.3.2 Symptoms 13
2.3.3 Co-morbidities and Complications 13
2.3.4 Epidemiology 14
2.4 Hepatitis B Virus 14
2.4.1 Overview 14
2.4.2 Symptoms 15
2.4.3 Co-morbidities and Complications 15
2.4.4 Epidemiology 16

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Friday, 23 September 2016

Human Immunodeficiency Virus (HIV) - Japan Drug Forecast and Market Analysis to 2023 including epidemiology, etiology, symptoms, diagnosis, pathology

ResearchMoz added Latest Research Report titled " Human Immunodeficiency Virus (HIV) - Japan Drug Forecast and Market Analysis to 2023 " to it's Large Report database.

Human Immunodeficiency Virus (HIV) - Japan Drug Forecast and Market Analysis to 2023

Summary

Human immunodeficiency virus (HIV) is a retrovirus that infects the cells of the immune system, destroying or impairing their function. As the infection progresses, the immune system becomes increasingly weaker, making the infected person more susceptible to other infections. Since the first anti-HIV drug, GlaxoSmithKlines (GSKs) Retrovir (azidothymidine), was approved in 1987, major improvements have been made in the field of antiretroviral therapy (ART). This rapid progress has been headlined by the emergence of once-daily, single-tablet regimens (STRs) such as Gilead Science's Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate [TDF]), which offer patients an unparalleled level of convenience.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=816337

The Japanese HIV market also differs from that of the US and the 5EU in that the uptake of STRs has been less pronounced. For example, Atripla, which has become a leading HIV drug across the 6MM, is not currently licensed in Japan. Gileads Stribild, an INI-based STR that was approved by the FDA in August 2012, became the first STR to be licensed in Japan, in early 2013 (Japan Tobacco, press release, March 25, 2013).

Scope

- Overview of Human Immunodeficiency Virus (HIV) including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the Japan including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the Japan from 2013-2023.
- Analysis of the impact of key events as well the drivers and restraints affecting the Japan Human Immunodeficiency Virus (HIV) market.

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 12
2 Introduction 13
2.1 Catalyst 13
2.2 Related Reports 14
2.3 Upcoming Related Reports 14
3 Disease Overview 15
3.1 Etiology 15
3.1.1 Viral Lifecycle 15
3.2 Pathophysiology 18
3.3 Staging and Symptoms 19
3.3.1 Primary or Acute Infection 19
3.3.2 Chronic Infection 20
3.3.3 Advanced Infection/AIDS 20
3.4 Prognosis 22
3.5 Quality of Life 22
4 Disease Management 24
4.1 Diagnosis and Treatment Overview 24
4.1.1 Screening and Diagnosis 24
4.1.2 Treatment Guidelines and Leading Prescribed Drugs 25
4.1.3 Clinical Practice 27
US Key Opinion Leader 27
4.2 Japan 38
4.2.1 Screening and Diagnosis 39
4.2.2 Clinical Practice 39

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Human Immunodeficiency Virus (HIV) - Current and Future Players Market Analysis Forecasts Research Report

ResearchMoz added Latest Research Report titled " Human Immunodeficiency Virus (HIV) - Current and Future Players " to it's Large Report database.

Human Immunodeficiency Virus (HIV) - Current and Future Players

Summary

GlobalData has released its pharma report, Human Immunodeficiency Virus (HIV) - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Human Immunodeficiency Virus (HIV) Market. The report identifies and analyses the key companies shaping and driving the global Human Immunodeficiency Virus (HIV) market. The report provides insight into the competitive Human Immunodeficiency Virus (HIV) landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalDatas team of industry experts.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=816329

Scope

- Investigation of current and future market competition for Human Immunodeficiency Virus (HIV)
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Human Immunodeficiency Virus (HIV) sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Human Immunodeficiency Virus (HIV) market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- Whats the next big thing in the global Human Immunodeficiency Virus (HIV) market landscape? Identify, understand and capitalize

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Catalyst 6
2.2 Related Reports 7
2.3 Upcoming Related Reports 7
3 Market Outlook 8
3.1 Global Markets 8
3.1.1 Forecast 8
3.1.2 Drivers and Barriers - Global Issues 14
4 Current and Future Players 17
4.1 Overview 17
4.2 Trends in Corporate Strategy 19
4.3 Company Profiles 21
4.3.1 Gilead Sciences 21
4.3.2 ViiV Healthcare 26
4.3.3 AbbVie 31
4.3.4 Merck & Co. 34
4.3.5 Janssen 38

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG